HPDL: 4-Hydroxyphenylpyruvate Dioxygenase-Like Gene

A gene encoding a putative dioxygenase involved in aromatic amino acid metabolism and linked to neurodevelopmental disorders.

Gene Information Card

Symbol HPDL
Full Name 4-Hydroxyphenylpyruvate Dioxygenase-Like
Gene Type Protein-coding
Chromosomal Location 1p34.3
NCBI Gene ID 84842 ncbi.nlm.nih.gov/gene/84842
Ensembl ID ENSG00000143178
UniProt ID Q96IR7
OMIM ID 618994
HGNC ID 28203
Aliases HPDL1, MGC13170

Description

HPDL (4-Hydroxyphenylpyruvate Dioxygenase-Like) encodes a protein that shares sequence similarity with 4-hydroxyphenylpyruvate dioxygenase (HPD), an enzyme involved in tyrosine catabolism. The HPDL protein is predicted to function as a dioxygenase, though its exact biochemical substrate remains under investigation. Biallelic loss-of-function mutations in HPDL cause an autosomal recessive neurodevelopmental disorder characterized by progressive spasticity, developmental delay, and white matter abnormalities.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities (NEDSWMA) Biallelic loss-of-function mutations in HPDL lead to deficiency of the HPDL protein, impairing mitochondrial function and causing neurodegeneration. OMIM #618994; ClinVar; PMID: 31730859
Spastic paraplegia, intellectual disability, and seizures HPDL variants disrupt normal neuronal development and myelination, resulting in motor and cognitive deficits. ClinVar; PMID: 31730859

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 3.2 nTPM Low
Liver 1.8 nTPM Low
Kidney 1.5 nTPM Low
Heart 1.2 nTPM Low
Testis 0.9 nTPM Not detected
Cell Line Expression
Cell Line nTPM Notes
SH-SY5Y (neuroblastoma) 2.5 nTPM Neuronal model
HEK293 (embryonic kidney) 1.0 nTPM Low expression
HepG2 (hepatocellular carcinoma) 0.8 nTPM Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1A>G (p.Met1?) Missense (start loss) Rare Loss of protein translation; associated with NEDSWMA
c.152C>T (p.Pro51Leu) Missense Rare Impaired protein stability; pathogenic in ClinVar
c.403C>T (p.Arg135*) Nonsense Rare Premature stop; loss-of-function; reported in affected individuals
Mutation functional classification

Loss of Function (LOF)

Biallelic loss-of-function mutations (nonsense, frameshift, start loss) cause HPDL deficiency, leading to neurodevelopmental disorder.

Gain of Function (GOF)

No evidence of gain-of-function mutations in HPDL.

Dominant Negative (DN)

No evidence of dominant-negative effects; disease is recessive.

Gene Ontology (GO)

catalytic activity (GO:0003824) • oxidoreductase activity, acting on single donors with incorporation of molecular oxygen (GO:0016702)
mitochondrion (GO:0005739) tyrosine catabolic process (GO:0006572)

Pathways

Tyrosine metabolism (KEGG: hsa00350)
Phenylalanine and tyrosine biosynthesis (Reactome: R-HSA-8978868)

Protein Summary

The HPDL protein (UniProt Q96IR7) is a 393-amino acid putative dioxygenase localized to mitochondria. It contains a conserved 2-oxoglutarate-dependent dioxygenase domain. Although its precise enzymatic function is not fully defined, it is thought to participate in aromatic amino acid metabolism. Loss of HPDL leads to mitochondrial dysfunction and oxidative stress, particularly affecting the central nervous system.

Related Products

Product name Cat.No. Species Gene ID
HPDL Knockout HEK293 Cell Line EDJ-KQ1214 Human 84842 Details Get a Quote
HPDL Knockout A-549 Cell Line EDJ-KQ21834 Human 84842 Details Get a Quote
HPDL Knockout HeLa Cell Line EDJ-KQ21836 Human 84842 Details Get a Quote
HPDL Knockout HCT 116 Cell Line EDJ-KQ74595 Human 84842 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: